Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

Table of Contents May 15, 2015; Volume Issue supplement 3 SNM 2015 Meeting Abstracts

  • RPSC Young Investigator Award Symposium
  • Nuclear Oncology Young Investigator Award Symposium
  • Head and Neck I
  • Cardiovascular Young Investigator Award Symposium
  • Brain Imaging Council Young Investigator Award Symposium
  • Sarcoma/Melanoma
  • Image Generation: SPECT Physics & Reconstruction
  • Gastroenterology
  • CMIIT Young Investigator Award Symposium
  • Prostate Cancer Imaging
  • Head and Neck II
  • Herrmann Blumgart Lecture & Award Session
  • Movement Disorders
  • Nephrourology
  • Computer & Instrumentation Council Young Investigator Award Symposium
  • Dosimetry
  • INTEGRATED Session: Molecular Imaging of Prostate Cancer
  • Novel Targeted Agents I
  • Lung Cancer I: Beyond FDG
  • SPECT and PET - New Methods and Techniques
  • Tau Imaging
  • INTEGRATED Session: Neuroendocrine Highlights
  • Data Analysis: Brain
  • Image-Guided Therapy I
  • Automation and Process Development
  • Novel Targeted Agents II
  • Lung Cancer II: PET/CT-Derived Prognostic Variables
  • INTEGRATED Session: PET, MRI and PET/MRI: Emerging Applications in Cardiovascular Medicine
  • Amyloid Imaging
  • What's New in Parathyroid Imaging
  • INTEGRATED Session: Cardiac PET
  • Image-Guided Therapy II
  • Radiochemistry with Fluorine-18
  • Cell Labeling and Lymphatics
  • Lung Cancer III
  • Myocardial Perfusion - Quantification and Outcome
  • INTEGRATED Session: New Targets in Alzheimer's Disease
  • Advances in Management of Thyroid Cancer
  • Image Generation: PET/CT & PET/MR: Quantitation
  • Emerging Technology in Neuroendocrine Imaging
  • Radiochemistry with Gallium-68, Copper-64 and Zirconium-89
  • Radiopharmaceutical Therapy I
  • Breast Cancer - FDG for Dection, Staging, Response, and Prognosis
  • Clinical Molecular Imaging I: Sarcoidosis, Inflammation and Infection
  • Dopamine and Dopamine Release in Neuropsychiatric Disorders
  • Infectious Disease/Hematology
  • Instrumentation: High-Resolution Imaging
  • Brain Tumors
  • Current Topics in PET Drug Quality Assurance
  • Radiopharmaceutical Therapy II
  • Gynecological
  • Clinical Molecular Imaging II: Vascular Imaging
  • Novel Tracers
  • Musculoskeletal: Arthritis & Related Topics
  • Data Analysis: Oncology
  • Pulmonary Embolism, Inflammation Imaging
  • Novel Nonradioactive Probes
  • Radiopharmaceutical Therapy III
  • Prostate/GU I
  • Clinical Molecular Imaging III: Myocardial Innervation and Remodeling
  • Neurodegeneration: Preclinical to Clinical
  • Pediatrics
  • Data Analysis: Quantification
  • Instrumentation: Clinical Imaging
  • New Technologies: Tc-99m Production, Rb-82 Elution System and Ga-68 Agents
  • Image Analysis In Oncology
  • Prostate/GU II
  • Atherosclerosis
  • Inflammation & BBB
  • Outcomes/Comparative Effectiveness
  • Image Generation: PET/CT & PET/MR: Motion
  • Preclinical of Neuroimaging
  • Preclinical Probes for Oncology I
  • FDG PET/CT
  • Prostate/GU III
  • Cardiac
  • Psychiatry, Obesity, Depression and Alcoholism
  • Thyroid Cancer New Updates
  • Data Analysis: Body Imaging
  • Musculoskeletal: Bone Surgery & More
  • Preclinical Probes for Oncology II
  • Image Generation: PET Reconstruction
  • Breast Cancer - Novel Methods and Approaches
  • Liver & Colorectal Cancers
  • Quantitative Oncology Imaging
  • Preclinical Probes for Cardiovascular, Endocrine & Other I
  • Leukemia/Lymphoma/Myeloma I
  • Instrumentation: Detector Concepts
  • AD Related Imaging
  • Preclinical Probes for Oncology III
  • Data Analysis: Modeling Methods
  • Other Tumors
  • GI Cancers (Non-Colorectal/Liver)
  • New Oncology Imaging Methods
  • Preclinical Probes for Cardiovascular, Endocrine & Other II
  • Leukemia/Lymphoma/Myeloma II
  • All About Benign Thyroid Diseases
  • Special MTA: Automation and Process Development Posters
  • Special MTA: Dosimetry Posters
  • Special MTA: Novel Nonradioactive Probes Posters
  • Special MTA: Novel Radiochemistry & Chelation Posters
  • Special MTA: Preclinical Probes for Cardiovascular, Endocrine & Other Posters
  • Special MTA: Preclinical Probes for Neuroimaging Posters
  • Special MTA: Preclinical Probes for Oncology Posters
  • Special MTA: Radiopharmacy Posters
  • MTA I: Basic Science Posters
  • MTA I: Image-Guided Therapy Posters
  • MTA I: Radiopharmaceutical Therapy Posters
  • MTA I: Technical Advances & Quantification Posters
  • MTA I: Head and Neck Posters
  • MTA I: Breast Cancer Posters
  • MTA I: GI-Colorectal & Liver Posters
  • MTA I: Gynecological Posters
  • MTA I: Leukemia/Lymphoma/Myeloma Posters
  • MTA I: Lung Cancer Posters
  • MTA I: GI-Non-colorectal Posters
  • MTA I: Other Tumors Posters
  • MTA I: Prostate/GU Posters
  • MTA I: Sarcoma/Melanoma Posters
  • MTA II: Cardiovascular Basic Science Posters
  • MTA II: Cardiovascular Clinical Science Posters
  • MTA II: Neurosciences: Basic Science Posters
  • MTA II: Neurology Posters
  • MTA II: Psychiatry Posters
  • MTA II: Endocrinology/Neuroendocrine Posters
  • MTA II: Gastroenterology Posters
  • MTA II: Infectious Disease/Hematology Posters
  • MTA II: Musculoskeletal Posters
  • MTA II: Outcome/Comparative Effectiveness Posters
  • MTA II: Pediatric Posters
  • MTA II: Pulmonary Posters
  • MTA II: Renal/Hypertension Posters
  • MTA II: Data Analysis & Management Posters
  • MTA II: Image Generation Posters
  • MTA II: Instrumentation Posters
  • Technologists Papers I: Radiopharmacy
  • Technologists Papers II: Professional Practices
  • Technologists Papers III: Diagnostic & Therapeutic Nuclear Medicine
  • Technologists Papers IV: Clinical PET
  • Technologists Papers V: Cardiovascular
  • Technologist Meet the Author Poster Session
  • Technologist Student Scientific Papers I
  • Technologist Student Scientific Papers II
  • Technologist Student Scientific Papers III
  • Educational Exhibits Digital Posters Session
Back to top
PreviousNext

In this issue

Journal of Nuclear Medicine
Vol. 56, Issue supplement 3
May 15, 2015
  • Table of Contents
  • Index by author
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • MIRD Pamphlet No. 28, Part 1: MIRDcalc—A Software Tool for Medical Internal Radiation Dosimetry
  • Absorbed Dose–Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [177Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine
  • Prediction of 177Lu-DOTATATE PRRT Outcome Using Multimodality Imaging in Patients with Gastroenteropancreatic Neuroendocrine Tumors: Results from a Prospective Phase II LUMEN Study
  • Renal and Multiorgan Safety of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer in the VISION Dosimetry Substudy
  • High-Temporal-Resolution Lung Kinetic Modeling Using Total-Body Dynamic PET with Time-Delay and Dispersion Corrections
More...
SNMMI

© 2025 SNMMI

Powered by HighWire